Oppenheimer & Co. Inc. boosted its stake in Exelon Co. (NYSE:EXC) by 4.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,747 shares of the energy giant’s stock after buying an additional 1,157 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Exelon were worth $1,240,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of EXC. Mercer Global Advisors Inc. ADV purchased a new stake in Exelon in the first quarter valued at $2,460,000. Boston Advisors LLC raised its holdings in shares of Exelon by 46.9% in the first quarter. Boston Advisors LLC now owns 154,088 shares of the energy giant’s stock valued at $7,724,000 after buying an additional 49,217 shares during the last quarter. Advisor Partners LLC increased its stake in shares of Exelon by 32.2% during the first quarter. Advisor Partners LLC now owns 24,785 shares of the energy giant’s stock worth $1,242,000 after acquiring an additional 6,030 shares during the period. Trinity Legacy Partners LLC acquired a new position in shares of Exelon during the first quarter worth about $207,000. Finally, Lantz Financial LLC acquired a new position in shares of Exelon during the first quarter worth about $488,000. 79.25% of the stock is currently owned by hedge funds and other institutional investors.
EXC stock traded down $0.10 during mid-day trading on Friday, hitting $49.56. 3,016,814 shares of the company were exchanged, compared to its average volume of 5,290,055. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.02 and a quick ratio of 0.89. Exelon Co. has a twelve month low of $39.63 and a twelve month high of $51.03. The firm has a market cap of $47.84 billion, a P/E ratio of 15.88, a P/E/G ratio of 4.14 and a beta of 0.37.
Exelon (NYSE:EXC) last posted its quarterly earnings results on Thursday, May 2nd. The energy giant reported $0.87 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.87. Exelon had a net margin of 6.52% and a return on equity of 8.85%. The company had revenue of $9.48 billion for the quarter, compared to the consensus estimate of $9.10 billion. During the same period last year, the firm posted $0.96 EPS. The company’s revenue for the quarter was down 2.2% on a year-over-year basis. On average, sell-side analysts expect that Exelon Co. will post 3.13 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 10th. Investors of record on Wednesday, May 15th will be given a $0.3625 dividend. The ex-dividend date is Tuesday, May 14th. This represents a $1.45 annualized dividend and a yield of 2.93%. Exelon’s dividend payout ratio is presently 46.47%.
In other news, EVP Paymon Aliabadi sold 17,500 shares of Exelon stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $48.36, for a total value of $846,300.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Joseph Nigro sold 53,800 shares of Exelon stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $49.59, for a total transaction of $2,667,942.00. Following the completion of the transaction, the executive vice president now directly owns 99,574 shares in the company, valued at $4,937,874.66. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.
A number of research analysts have recently issued reports on the stock. Wells Fargo & Co upgraded shares of Exelon from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $50.00 to $57.00 in a research note on Tuesday, April 2nd. Goldman Sachs Group upgraded shares of Exelon from a “sell” rating to a “neutral” rating and upped their target price for the stock from $43.00 to $47.00 in a research report on Tuesday, April 9th. Mizuho upped their target price on shares of Exelon from $47.00 to $49.50 and gave the stock a “neutral” rating in a research report on Thursday, May 16th. Morgan Stanley increased their price target on shares of Exelon from $52.00 to $53.00 and gave the company an “equal weight” rating in a research report on Thursday, May 16th. Finally, Scotiabank reiterated a “buy” rating and issued a $50.00 price target on shares of Exelon in a research report on Wednesday, February 13th. Seven investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $48.97.
TRADEMARK VIOLATION WARNING: This piece was originally posted by Sundance Herald and is owned by of Sundance Herald. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://sundanceherald.com/2019/05/24/oppenheimer-co-inc-purchases-1157-shares-of-exelon-co-exc.html.
Exelon Company Profile
Exelon Corporation, a utility services holding company, engages in energy generation and delivery businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.
Featured Story: Understanding Specialty Certificates of Deposit
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.